
Orchid Pharma Limited has informed the Exchange regarding a press release dated February 23, 2024, titled "Orchid Pharma's 'Exblifep' receives USFDA approval: A new milestone for India's Pharmaceutical industry".
Filed with NSE ·

Orchid Pharma Limited has informed the Exchange regarding a press release dated February 23, 2024, titled "Orchid Pharma's 'Exblifep' receives USFDA approval: A new milestone for India's Pharmaceutical industry".
6ix hasn’t read this filing yet.
Follow Orchid Pharma into a list and get an email when it puts out news.
Follow Orchid Pharma